No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ABT Abbott Laboratories
- 106.890
- -0.700-0.65%
Close Apr 24 16:00 ET
- 106.230
- -0.660-0.62%
Post 19:40 ET
185.47BMarket Cap33.30P/E (TTM)
107.110High105.560Low5.05MVolume106.710Open107.590Pre Close538.34MTurnover0.29%Turnover Ratio32.79P/E (Static)1.74BShares121.03952wk High4.80P/B184.26BFloat Cap88.80152wk Low2.08Dividend TTM1.72BShs Float136.153Historical High1.95%Div YieldTTM1.44%Amplitude6.525Historical Low106.545Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | NYSE Order Imbalance 52756.0 Shares on Sell Side
Europe In-Vitro Diagnostics (IVD) Markets, 2023-2024 & 2029 With Abbott, BioMerieux, Danaher, Hoffmann-La Roche, Bio-Rad, Siemens Healthineers, Thermo Fisher Scientific, and Diasorin Dominating
Express News | NYSE Order Imbalance 105010.0 Shares on Buy Side
Express News | NYSE Order Imbalance 94717.0 Shares on Buy Side
Investors Heavily Search Abbott Laboratories (ABT): Here Is What You Need to Know
Abbott Labs Is Maintained at Overweight by Barclays
Abbott Labs Is Maintained at Overweight by Barclays
Comments
ColumnsToday's Morning Movers and Top Ratings: ASML, LLY, ADSK, UAL and More
Morning Movers
Gapping up
$United Airlines(UAL.US$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
Gapping up
$United Airlines(UAL.US$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
26
ColumnsPreview of Abbott's Q1 performance: The COVID-19 pandemic dividend dissipates, and cost pressures increase
$Abbott Laboratories(ABT.US$
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
1
$Abbott Laboratories(ABT.US$ Hmmm. As usual, red again
Insiders selling shares with no recorded purchases over the last year could worry investors. Despite high insider ownership, recent selling activity suggests insiders don't see shares as a bargain.
The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg